Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01641159 · ClinicalTrials.gov registry record · Phase 2
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
A Phase 2 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT01641159 is a Phase 2 study that has completed, run by University of Cincinnati. The registered enrollment target is 62 participants.
The verdict
NCT01641159, a Phase 2 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether or not buspirone is effective in preventing relapse in cocaine-dependent adults in inpatient/residential treatment who are planning to enter outpatient treatment upon inpatient/residential discharge.
Interventions
- DRUG Placebo
- DRUG Buspirone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01641159
The ClinicalTrials.gov registry entry for NCT01641159 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01641159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01641159 about?
NCT01641159 is a clinical study titled "Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence". The purpose of this study is to evaluate whether or not buspirone is effective in preventing relapse in cocaine-dependent adults in inpatient/residential treatment who are planning to enter outpatient treatment upon inpatient/residential discharge.
What is the current status of trial NCT01641159?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2012-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01641159?
The interventions under investigation include: Placebo (DRUG), Buspirone (DRUG).
Who is sponsoring clinical trial NCT01641159?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.